[ad_1]
The S&P 500 index is up over 14% year to date and the Nasdaq Composite is up 18%, but retail investors still think cash is king.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...